Skip to main content

Table 2 Distribution of KRAS and BRAF mutations according to patients’ characteristics

From: EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma

Characteristics

Number of patients (%)

KRAS mutated cases

BRAF mutated cases

No.

%

p

No.

%

p

Total cases analyzed

1047

231

22.1

 

34

3.2

 

Sex

 Males

693 (66)

169

24.4

0.018

25

3.6

0.462

 Females

354 (34)

61

17.2

9

2.5

Age at diagnosis

 ≤ 50 years

94 (9)

24

25.5

0.472*

3

3.2

1.000*

 51–60 years

189 (18)

46

24.3

7

3.7

 61–70 years

394 (38)

78

19.9

10

2.5

 > 70 years

370 (35)

83

22.4

14

3.6

Smoking habitus

 Smoker

336 (32)

74

22.0

0.001**

14

4.2

0.411**

 Former smoker

367 (35)

89

24.3

10

2.7

 Never smoker

139 (13)

14

10.1

2

1.4

 Unknown

205 (20)

54

26.3

 

8

3.9

 

Type of sample

 Primary tumor

889 (85)

197

22.2

0.940

29

3.3

1.000

 Metastasis

158 (15)

34

21.5

5

3.2

Sample’s origin

 Biopsy

848 (81)

193

22.8

0.304

28

3.3

0.987

 Surgery

199 (19)

38

19.1

6

3.0

  1. * Patients ≤ 50 years vs patients ≥ 50 years; ** Never smokers vs smokers and ex-smokers; significance at 0.05